-
Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects. The company’s stock valuation also surged, hitting $29 billion, an astonishing feat for a company that currently sells zero products. But was there good reason for so much enthusiasm? Several vaccine experts asked by STAT concluded that, based on the information made available by the Cambridge, Mass.-based company, there’s really no way to know how impressive — or not — the vaccine may be. While Moderna blitzed the ... (full story)
- Comments
- Comment
- Subscribe
- Comment #1
- Quote
- May 19, 2020 3:38pm May 19, 2020 3:38pm
- redlabel
- | Joined Feb 2018 | Status: Member | 10 Comments
- Comment #2
- Quote
- May 19, 2020 3:52pm May 19, 2020 3:52pm
- Banditten
- Joined Sep 2019 | Status: Member | 1472 Comments
- Comment #3
- Quote
- Edited 8:48pm May 19, 2020 8:26pm | Edited 8:48pm
- 4for4
- | Joined Apr 2017 | Status: 38737526 / 29052019 | 269 Comments
Market is not random but unpredictable
- Comment #4
- Quote
- May 19, 2020 10:21pm May 19, 2020 10:21pm
- penuelophir
- | Joined Aug 2014 | Status: Member | 82 Comments
- Comment #5
- Quote
- May 19, 2020 11:09pm May 19, 2020 11:09pm
- Nikt
- | Joined Mar 2017 | Status: Member | 3 Comments
- Comment #6
- Quote
- May 20, 2020 1:20am May 20, 2020 1:20am
- Micc23
- | Joined May 2017 | Status: Member | 848 Comments
- Comment #7
- Quote
- Edited 2:50am May 20, 2020 2:39am | Edited 2:50am
- Nikt
- | Joined Mar 2017 | Status: Member | 3 Comments
- Comment #8
- Quote
- May 20, 2020 6:41am May 20, 2020 6:41am
- RossEdwards
- Joined Jun 2019 | Status: Member | 3299 Comments
Warning: A Dangerous Subversive: 1% of comments CoCed